Skip to content
10-Q

Quarterly Report

AVALON GLOBOCARE CORP. ALBT

0001213900-26-054548

← back to feed
Filed
May 11, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 11, 2026 12.05M sh
Shares Diluted Q1 2026 · Mar 31, 2026 8.96M sh
Shares Diluted Q1 2026 · Mar 31, 2025 1.62M sh
Cash And Equivalents Q1 2026 · Mar 31, 2026 $776K
Cash And Equivalents Q1 2026 · Dec 31, 2025 $109.09K
Stockholders Equity Q1 2026 · Mar 31, 2026 $11.72M
Stockholders Equity Q1 2026 · Dec 31, 2025 $9.23M
Current Liabilities Q1 2026 · Mar 31, 2026 $4.44M
Current Liabilities Q1 2026 · Dec 31, 2025 $14.15M
Total Liabilities Q1 2026 · Mar 31, 2026 $4.52M
Total Liabilities Q1 2026 · Dec 31, 2025 $14.17M
Current Assets Q1 2026 · Mar 31, 2026 $1.67M
Current Assets Q1 2026 · Dec 31, 2025 $1.5M
Total Assets Q1 2026 · Mar 31, 2026 $16.25M
Total Assets Q1 2026 · Dec 31, 2025 $23.4M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.50
Eps Diluted Q1 2026 · Mar 31, 2025 −$1.43
Eps Basic Q1 2026 · Mar 31, 2026 −$0.50
Eps Basic Q1 2026 · Mar 31, 2025 −$1.43
Net Income Q1 2026 · Mar 31, 2026 −$4.48M
Net Income Q1 2026 · Mar 31, 2025 −$2.48M
Operating Income Q1 2026 · Mar 31, 2026 −$2.72M
Operating Income restated Q1 2026 · Mar 31, 2025 −$1.79M